ICU Medical, Inc. (NASDAQ:ICUI) Director Elisha W. Finney sold 2,424 shares of the firm’s stock in a transaction dated Tuesday, September 14th. The shares were sold at an average price of $242.20, for a total transaction of $587,092.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
ICU Medical stock opened at $239.22 on Wednesday. The company’s 50 day simple moving average is $202.38 and its 200 day simple moving average is $204.47. ICU Medical, Inc. has a fifty-two week low of $176.18 and a fifty-two week high of $282.00. The firm has a market capitalization of $5.07 billion, a price-to-earnings ratio of 50.15 and a beta of 0.60.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 4th. The medical instruments supplier reported $1.57 earnings per share for the quarter, topping the consensus estimate of $1.43 by $0.14. ICU Medical had a net margin of 8.07% and a return on equity of 8.67%. The business had revenue of $321.68 million for the quarter, compared to analyst estimates of $306.30 million. As a group, research analysts anticipate that ICU Medical, Inc. will post 6.18 EPS for the current fiscal year.
Several equities research analysts have recently commented on the stock. KeyCorp lifted their price target on shares of ICU Medical from $225.00 to $302.00 and gave the stock an “overweight” rating in a research report on Thursday, September 9th. Raymond James lifted their price target on shares of ICU Medical from $220.00 to $286.00 and gave the stock an “outperform” rating in a research report on Thursday, September 9th. Finally, Zacks Investment Research cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, August 11th.
About ICU Medical
ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.
Recommended Story: Understanding Market Liquidity
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.